Pathogenesis of proliferative lupus nephritis from a historical and personal perspective

Clinical Immunology

Volumn 185, Issue , 2017, Pages 51-58

  Fu, Shu Man ^a   Wang, Hongyang ^a   Dai, Chao ^a   Sung, Sun sang J ^a   Gaskin, Felicia ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Autoimmune diseases; Autoimmunity; End organ resistance to damage; Immune complex mediated diseases; Lupus nephritis

Indexed keywords

CELL NUCLEUS ANTIGEN; DOUBLE STRANDED DNA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; DISEASE COURSE; END STAGE RENAL DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; NUCLEOSOME; PATHOGENESIS; PRIORITY JOURNAL; ANIMAL; HUMAN; IMMUNOLOGY;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; HUMANS; LUPUS NEPHRITIS;

EID: 85009952127     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2016.07.024     Document Type: Article

References (32)

1. Cameron, J.S., Lupus nephritis: an historical perspective 1968–1998. J. Nephrol. 12:Suppl. 2 (1999), s29–s41.
2. Baehr, G., Klemperer, P., Schifren, A., A diffuse disease of the peripheral circulation (usually associated with lupus erythematosus and endocarditis). Trans. Assoc. Am. Phys. 50 (1935), 139–155.
3. Vazquez, J.J., Dixon, F.J., Immunohistochemical study of lesions in rheumatic fever, systemic lupus erythematosus, and rheumatoid arthritis. Lab. Investig. 6 (1957), 205–217.
4. Holman, H.R., Kunkel, H.G., Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 126 (1957), 162–163.
5. Koffler, D., Schur, P.H., Kunkel, H.G., Immunological studies concerning the nephritis of systemic lupus erythematosus. J. Exp. Med. 126 (1967), 607–624.
6. Koffler, D., Agnello, V., Carr, R.I., Kunkel, H.G., Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus. Am. J. Pathol. 56 (1969), 305–316.
7. Kunkel, H.G., Mechanisms of renal injury in systemic lupus erythematosus. Arthritis Rheum. 9 (1966), 725–726.
8. Tan, E.M., Schur, P.H., Carr, R.I., Kunkel, H.G., Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 45 (1966), 1732–1740.
9. TN, C.M., AE, P., Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus. Semin. Immunopathol. 6 (2014), 495–517.
10. Fu, S.M., Dai, C., Zhao, Z., Gaskin, F., Anti-dsDNA Antibodies are one of the Many Autoantibodies in Systemic Lupus Erythematosus. F1000Res. 4, 2015 Oct 1, F1000 Faculty Rev, 939, 10.12688/f1000research.6875.1 (eCollection 2015).
11. Mannik, M., Merrill, C.E., Stamps, L.D., Wener, M.H., Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J. Rheumatol. 30 (2003), 1495–1504.
12. Pedersen, H.L., Horvei, K.D., Thiyagarajan, D., Seredkina, N., Rekvig, O.P., Murine and human lupus nephritis: pathogenic mechanisms and theoretical strategies for therapy. Semin. Nephrol. 35 (2015), 427–438.
13. Goilav, B., Putterman, C., The role of anti-DNA antibodies in the development of lupus nephritis: a complementary, or alternative, viewpoint?. Semin. Nephrol. 35 (2015), 439–443.
14. Waters, S.T., McDuffie, M., Bagavant, H., Deshmukh, U.S., Gaskin, F., Jiang, C., et al. Breaking tolerance to double stranded DNA, nucleosome and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J. Exp. Med. 199 (2004), 255–264.
15. Waters, S.T., Fu, S.M., Gaskin, F., Deshmukh, U.S., Sung, S.-sJ., Kannapell, C.C., et al. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin. Immunol. 100 (2001), 372–383.
16. Bruschi, M., Sinico, R.A., Moroni, G., Pratesi, F., Migliorini, P., Galetti, M., et al. Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI. J. Am. Soc. Nephrol. 25 (2014), 2483–2498.
17. Moroni, G., Bonanni, A., Radice, A., et al. Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): planted antigens. J. Am. Soc. Nephrol. 26 (2015), 1905–1924.
18. Seret, G., Cañas, F., Pougnet-Di Costanzo, L., Hanrotel-Saliou, C., Jousse-Joulin, S., Le Meur, Y., Saraux, A., Valeri, A., Putterman, C., Youinou, P., Rojas-Villarraga, A., Anaya, J.M., Renaudineau, Y., Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis. J. Autoimmun. 61 (2015), 54–61.
19. Dai, C., Deng, Y., Quinlan, A., Gaskin, F., Tsao, B.P., Fu, S.M., Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage. Curr. Opin. Immunol. 31 (2014), 87–96.
20. Ge, Y., Jiang, C., Sung, S.-sJ., Bagavant, H., Dai, C., Wang, H., et al. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J. Exp. Med. 210 (2013), 2387–2401.
21. Schiffer, L., Bethunaickan, R., Ramanujam, M., Huang, W., Schiffer, M., Tao, H., et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J. Immunol. 180 (2008), 1938–1947.
22. Bethunaickan, R., Berthier, C.C., Ramanujam, M., Sahu, R., Zhang, W., Sun, Y., et al. A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis. J. Immunol. 186 (2011), 4994–5003.
23. Dai, C., Wang, H., S-sJ, S., Sharma, R., Kannapell, C., Han, W., et al. Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure. Clin. Immunol. 154 (2014), 66–71.
24. Ge, Y., Prevention of Chronic Fatal Lupus Nephritis in NZM2328 Mice by Replacing the Chronic-Glomerulonephritis-Associated Cgnzl Locus and Identification of Candidate Cgnzl Genes (Doctoral Dissertation PHD Microbiology). 2009, UVA Libra, 97–101 (Retrieved from ).
25. Morel, L., Mapping lupus susceptibility genes in the NZM2410 mouse model. Adv. Immunol. 115 (2012), 113–139.
26. Morel, L., Blenman, K.R., Croker, B.P., Wakeland, E.K., The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. 2001. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 1787–1792.
27. Morel, L., Rudofsky, U.H., Longmate, J.A., Schiffenbauer, J., Wakeland, E.K., Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1 (1994), 219–229.
28. Chen, T.K., Estrella, M.M., Parekh, R.S., The evolving science of apolipoprotein-L1 and kidney disease. Curr. Opin. Nephrol. Hypertens. 25 (2016), 217–225.
29. Kotb, A.M., Simon, O., Blumenthal, A., Vogelgesang, S., Dombrowski, F., Amann, K., et al. Knockdown of ApoL1 in zebrafish larvae affects the glomerular filtration barrier and the expression of nephrin. PLoS One, 11, 2016, e0153768.
30. Johnstone, D.B., Shegokar, V., Nihalani, D., Rathore, Y.S., Mallik, L., Ashish, Zare V, Ikizler HO, Powar R, Holzman LB. APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis. PLoS One, 7, 2012, e51546.
31. Fu, S.M., Dai, C., Wang, H., Sung, S.-sJ., Gaskin, F., Mechanisms of renal damage in systemic lupus erythematosus. GC, T., (eds.) Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects, 1st edition, 2016, Elsevier Inc., London, UK, 283–293.
32. Whittier, W.L., Reiser, J., Lupus nephritis: through the looking-glass. Lupus 24 (2015), 533–535.